Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
R Matthew HutchisonKyle FraserMinhua YangTara FoxElizabeth HirschhornEdwin NjingtiDavid ScottBarry J BedellKristi M KistnerJesse M CedarbaumKarleyton C EvansDanielle GrahamLaurent MartarelloBrit MollenhauerAnthony E LangTien DamJohn BeaverPublished in: Neurology (2024)
NCT03318523 (clinicaltrials.gov/ct2/show/NCT03318523); Submitted October 24, 2017; First patient enrolled January 2018.